Higher Part D Premiums Whet Waxman’s Appetite For HHS Price Negotiation

Increasing Part D premiums have caught the eye of Rep. Henry Waxman, who sees them as further evidence that HHS would do a better job of negotiating drug prices for Part D than the private sector